Respiratory arrests in young asthmatics on salmeterol.

Suppr

超能文献

作者信息

Clark C E, Ferguson A D, Siddorn J A

机构信息

Department of Respiratory Medicine, Royal Devon & Exeter Hospital Wonford, Exeter, U.K.

出版信息

Respir Med. 1993 Apr;87(3):227-8. doi: 10.1016/0954-6111(93)90098-k.

DOI:10.1016/0954-6111(93)90098-k

PMID:8497705

Abstract

摘要

相似文献

Respiratory arrests in young asthmatics on salmeterol.

Respir Med. 1993 Apr;87(3):227-8. doi: 10.1016/0954-6111(93)90098-k.

Respiratory arrests in young asthmatics on salmeterol.

Respir Med. 1993 Nov;87(8):638-9. doi: 10.1016/s0954-6111(05)80276-8.

Respiratory arrests in young asthmatics on salmeterol.使用沙美特罗的年轻哮喘患者发生呼吸骤停。

Respir Med. 1994 Jan;88(1):75-6. doi: 10.1016/0954-6111(94)90184-8.

Salmeterol and tolerance.

Chest. 2000 Feb;117(2):609-11. doi: 10.1378/chest.117.2.609.

Long-acting bronchodilators: time for a re-think.长效支气管扩张剂：是时候重新思考了。

J R Soc Med. 2006 Aug;99(8):382-3. doi: 10.1177/014107680609900803.

[More asthma death cases with beta-2-antagonists: with inhaled corticosteroids on the safe side?].[使用β-2拮抗剂导致更多哮喘死亡病例：吸入性糖皮质激素是否更安全？]

MMW Fortschr Med. 2007 Dec 6;149(49-50):20. doi: 10.1007/BF03365251.

Salmeterol xinafoate in asthma.

JAMA. 1994;272(20):1575-6. doi: 10.1001/jama.272.20.1575a.

Asthma group issues guidelines for safe use of salmeterol.

Am J Health Syst Pharm. 1996 Dec 15;53(24):2943-4. doi: 10.1093/ajhp/53.24.2943.

Bronchodilator reversibility to albuterol predicts bronchodilator response to salmeterol.

Chest. 2002 Apr;121(4):1382. doi: 10.1378/chest.121.4.1382.

Salmeterol: its place in asthma management.

Ann Pharmacother. 1994 Sep;28(9):1100-2. doi: 10.1177/106002809402800916.

引用本文的文献

Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.用于成人和儿童慢性哮喘的长效β2受体激动剂，其背景治疗包含不同种类或不包含吸入性糖皮质激素。

Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD001385. doi: 10.1002/14651858.CD001385.pub2.

A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.吸入长效β2受体激动剂治疗阻塞性肺疾病的获益-风险评估

Drug Saf. 2004;27(10):689-715. doi: 10.2165/00002018-200427100-00001.

Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.长效β受体激动剂常规治疗与短效β受体激动剂每日常规治疗用于稳定期哮喘成人和儿童的比较

Cochrane Database Syst Rev. 2002;2002(4):CD003901. doi: 10.1002/14651858.CD003901.

Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?吸入性糖皮质激素无法控制的夜间哮喘：茶碱还是长效β2受体激动剂？

Drugs. 2001;61(3):391-418. doi: 10.2165/00003495-200161030-00007.

Asthma exacerbations during first therapy with long acting beta 2-agonists.长效β2受体激动剂首次治疗期间的哮喘加重

Pharm World Sci. 1999 Jun;21(3):116-9. doi: 10.1023/a:1008618700934.

Salmeterol. A review of its pharmacological properties and clinical efficacy in the management of children with asthma.沙美特罗。关于其药理特性及在儿童哮喘管理中的临床疗效的综述。

Drugs. 1997 Aug;54(2):331-54. doi: 10.2165/00003495-199754020-00011.

Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?长效β2受体激动剂导致的气道敏感性降低。是否需要担忧？

Drug Saf. 1997 May;16(5):295-308. doi: 10.2165/00002018-199716050-00002.

Bronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained.哮喘中的支气管扩张剂治疗。沙美特罗治疗期间死亡人数增加，原因不明。

BMJ. 1993 Jun 12;306(6892):1610-1. doi: 10.1136/bmj.306.6892.1610-c.

Long- versus short-acting beta 2-agonists. Implications for drug therapy.长效与短效β2受体激动剂。对药物治疗的影响。

Drugs. 1994 Feb;47(2):207-22. doi: 10.2165/00003495-199447020-00001.

Long-acting beta 2-agonists and their role in asthma management.长效β2受体激动剂及其在哮喘管理中的作用。

West J Med. 1995 Oct;163(4):372.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验